Ralph Charlton
Chief Tech/Sci/R&D Officer at SPRUCE BIOSCIENCES, INC.
Net worth: 38 816 $ as of 2024-04-29
Ralph Charlton active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-03-13 | - |
Career history of Ralph Charlton
Former positions of Ralph Charlton
| Companies | Position | Start | End |
|---|---|---|---|
| 89BIO, INC. | Chief Tech/Sci/R&D Officer | 2020-10-31 | 2022-01-31 |
| Ascendis Pharma, Inc. | Chief Tech/Sci/R&D Officer | 2019-04-30 | 2020-10-31 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 2018-06-30 | 2019-04-30 |
Training of Ralph Charlton
| University of Southern California | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| 89BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Ascendis Pharma, Inc. |
- Stock Market
- Insiders
- Ralph Charlton
- Experience
